Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.05
0.03 (2.94%)
At close: Aug 15, 2025, 2:13 PM

Coherus BioSciences Revenue

Coherus BioSciences reported an annual revenue of $266.96M, reflecting a 3.78% growth. For the quarter ending June 30, 2025, Coherus BioSciences generated $10.25M in revenue.
Revenue (ttm)
266.96M
Revenue Growth
3.78%
Price / Sales Ratio
0.59
Revenue / Employee
1.17M
Employees
228
Market Cap
122.04M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.